Düsseldorf (DE) Local Division
250 cases · page 9 of 9
Showing 241–249Dolby International AB v.HP Deutschland GmbH, HP Inc., HP International SARL, HP Austria GmbH, HP France SAS, HP Belgium SPRL, HP Inc Danmark ApS, HP Finland Oy, HP Italy S.r.l., Hewlett-Packard Nederland BV, HP PPS Sverige AB, HPCP – Computing and Printing Portugal, Hewlett-Packard d.o.o., Hewlett-Packard Luxembourg SCA, HP Inc Bulgaria EOOD
Dolby International AB initiated infringement proceedings against various HP entities regarding the European patent EP 3 490 258 B1, which covers HEVC video decoding technology. During the litigation, Dolby sought to restrict its claims to exclude products utilizing NVIDIA graphics cards. The Düsseldorf Local Division granted this request, formally narrowing the scope of the lawsuit. This decision is significant as it demonstrates how claimants can strategically refine their infringement allegations within the UPC framework.
10x Genomics, Inc. v.Curio Bioscience Inc.
In this UPC case concerning nucleic acid detection technology, 10x Genomics sought provisional measures against Curio Bioscience. The Düsseldorf Local Division granted an injunction, confirming the validity and scope of EP 2 697 391 B1. However, the court imposed strict conditions for enforcement, requiring 10x Genomics to post a substantial security deposit of EUR 2 million. This decision highlights the high threshold required for obtaining provisional relief in UPC infringement cases.
10x Genomics, Inc. v.Curio Bioscience Inc.
In this provisional measures case, the UPC Local Division in Düsseldorf examined a dispute over EP 2 697 391 B1, which covers methods for localized nucleic acid detection. Although the Applicant (10x Genomics) sought various remedies, including costs security and injunctions, the court largely rejected these requests. The final order is highly conditional: while provisional cost reimbursement was ordered, enforcement of any measures requires the Applicant to first deposit EUR 2 million with the Defendant.
10x Genomics, Inc. v.Curio Bioscience Inc.
This procedural order in the Düsseldorf Local Division of the Unified Patent Court (UPC) addresses a request by both parties to change the language of the ongoing infringement case. The claimant, 10x Genomics, Inc., initiated proceedings against Curio Bioscience Inc. regarding EP 2 697 391 B1. Both parties mutually agreed to switch the procedural language from German to English, which the court subsequently approved.
10x Genomics, Inc. v.Curio Bioscience Inc.
In a procedural order concerning an application for provisional measures in the Düsseldorf Local Division, the UPC addressed the complex issue of language change mid-litigation. Although the Court of Appeal had set English as the official language after the oral hearing was conducted in German, the court made an exceptional ruling. It allowed the final decision to be issued in German, provided it included a certified English translation, thereby balancing procedural fairness with the need for judicial efficiency.
Seoul Viosys Co., Ltd. v.expert e-Commerce GmbH
This decision from the Düsseldorf Local Division addresses a critical procedural issue regarding third-party intervention in UPC cases. Seoul Viosys Co., Ltd. sought to allow its licensee (Seoul Semiconductor Co., Ltd.) to join both an infringement lawsuit and a concurrent revocation counterclaim. The court ruled that the licensee possesses sufficient legal interest, particularly when the local division bundles both types of claims for unified interpretation. This ruling significantly clarifies the scope of participation rights for licensees in complex UPC litigation.
F. Hoffman-La Roche AG v.Rubin Medical ApS, c/o Diatom A/S, Tandem Diabetes Care Europe B.V.
In this UPC case concerning diabetes care technology, the court addressed multiple procedural challenges raised by defendants seeking to change the language of the proceedings from German to English. The claimants argued that such a change was not permissible under the EPC or Rules of Procedure. Ultimately, the court dismissed all requests for a language change, primarily due to technical failures in meeting strict filing deadlines, thereby maintaining the German language as the official procedural language.
F. Hoffman-La Roche AG v.Tandem Diabetes Care, Inc.
In this UPC case concerning diabetes care technology, the court addressed procedural challenges raised by several defendants seeking to change the language of proceedings from German to English. The claimants argued that the procedural language was fixed and could not be changed against their will. The court ultimately dismissed all requests for a language change, citing strict rules regarding filing deadlines and the lack of legal grounds for altering the established procedure.
Ortovox Sportartikel GmbH v.Mammut Sports Group AG
This UPC decision addressed a motion concerning provisional measures related to an avalanche rescue transceiver patent (EP 3 466 498 B1). The court upheld the existing injunction and security deposit requirement while granting preliminary costs relief to the claimant, Ortovox. The ruling also provided important procedural guidance on patent interpretation and cost allocation in interim proceedings when a main action is anticipated.
FUJIFILM Corporation v.Kodak GmbH, Kodak Graphic Communications GmbH, and Kodak Holding GmbH
In a procedural order concerning an infringement action, the UPC Local Division in Düsseldorf granted an extension of time to the claimant, FUJIFILM Corporation. The request was necessitated by the defendants' application for protection of confidential information (R. 262A RoP), which initially restricted access to key factual pleadings. The Court ruled that granting this extension is essential to uphold the principles of due process and ensure the claimant can properly develop its defense strategy based on all available facts.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.